Healt
6 Health Care Stocks - RMD, RHC, SHL, CSL, BIT And RHT
December 14, 2018 11:40 PM AEDT| By Team Kalkine MediaIf an investor is looking for the safest sectors in Australia, health care will be among the top few sectors even during uncertain times. As the aging population in developed countries continue to grow the need for health care will always be there fo...
RNO’s Shares Uplifted On ASX Following The Release Of Its Annual General Meeting Outcome
December 14, 2018 11:10 PM AEDT| By Team Kalkine MediaMedical technology company Rhinomed Limited (ASX: RNO) held its Annual General Meeting (AGM) on 14 December 2018.? All the resolutions at the AGM were passed. In total, there were 10 resolutions which included 2 special resolutions which required 75%...
CEO Declares GBI’s Distribution Agreement With Beckman And Its 12 Months Outlook In AGM
December 14, 2018 08:15 PM AEDT| By Team Kalkine MediaOn 14 December 2018, in the annual general meeting of Genera Biosystems Limited (ASX: GBI), the chief executive officer Mr. Richard Hannebery discloses its investors the corporate summary of GBI where he highlights information about its capital struc...
API’s Shares Mounted on ASX After Announcing a Merger Proposal to Sigma
December 14, 2018 02:53 PM AEDT| By Team Kalkine MediaAustralian Pharmaceutical Industries Limited (ASX: API) has become a substantial shareholder in Sigma Healthcare Limited (ASX: SIG) by holding 12.95 percent of its shares. Further, API has also reconfirmed the terms of a non-binding indicative propos...
Digital Health Player Adherium Announces Major Corporate Restructuring Plans
December 13, 2018 06:08 PM AEDT| By Team Kalkine MediaAdherium Limited (ASX: ADR) operates in the business segment of digital health technology providing technologies for medication use and remote patient management in chronic diseases. The company?s Hailie solution has proven to be very effective and i...
CYNATA Gets Major Funding From NHMRC For Second Phase Clinical Trial In Osteoarthritis
December 13, 2018 05:20 PM AEDT| By Team Kalkine MediaAustralian National Health and Medical Research Council (NHMRC) will fund a major second phase of clinical trial in osteoarthritis for CYNATA THERAPEUTICS LIMITED (ASX: CYP). Cynata being a biotechnology company has its specialization in cell therap...
Pharmaxis Ships First Order Of Re-Launched Asthma Drug Aridol In The US
December 13, 2018 03:47 PM AEDT| By Team Kalkine MediaAs per the latest ASX announcement, Pharmaxis Limited (ASX: PXS) has successfully completed the first sales of its asthma cure drug Aridol in United States post the relaunch of the product. Pharmaxis is a pharmaceutical company based out in Sydney,...
BOTANIX PHARMACEUTICALS Limited - A Biotech Developing Registered Cannabis For Skin Treatment
December 12, 2018 11:45 PM AEDT| By Team Kalkine MediaBotanix Pharmaceuticals Ltd (ASX: BOT) a dermatology company who is into delivering is currently targeting synthetic cannabinoids for skin disease treatment is now focusing on its multi-billion-dollar prescription markets that take care of acne, atop...
Cellmid Sheds Light On Scaling Of Distribution Channels
December 12, 2018 09:49 PM AEDT| By Team Kalkine MediaOn December 12, 2018, Cellmid Limited (ASX: CDY) has announced that the scheduled sales event on Japanese television shopping channel, QVC, delivered approximately $1.1 million sales revenue for the company, wholesale. Cellmid Limited?is a life scien...
HeraMED Successfully Lists On ASX Closing $6 Million IPO
December 12, 2018 09:40 PM AEDT| By Team Kalkine MediaIsraeli company HeraMED (ASX: HMD) successfully completes its IPO of $6 million (NIS 15.8 million) at A$0.20 per share and subsequently lists on Australian Stock Exchange. Official share trading on ASX begins tomorrow. HeraMED plans to utilize the ra...
BARD1 Life Sciences Limited Closed The Entitlement Offer
December 12, 2018 09:33 PM AEDT| By Team Kalkine MediaThe biotechnology company situated in Australia has announced that the non-renounceable Entitlement Offer to raise approximately $3.3 million, closed at 2:00 pm on Monday, 10 December 2018 as per the terms of the Offer. To subscribe for 59,141,273 ne...
Zenitas Healthcare Limited Implementing The New Arrangement
December 12, 2018 07:31 PM AEDT| By Team Kalkine MediaAs approved by the company?s shareholders on 14 November 2018 and the Supreme Court of Victoria (Court) on 16 November 2018 the scheme of arrangement between Zenitas and its shareholders has been implemented. Guardian Alphabet Pty Ltd?s wholly owned...
Impression Healthcare Limited On The License Application
December 12, 2018 06:05 PM AEDT| By Team Kalkine MediaThe company has lately announced that to possess and supply scheduled substances, including cannabinoid medicines, with the Department of Health, it has completed the pre-license stage and has accordingly lodged an application for a license, on 11th...
Sonic Healthcare To Acquire Aurora Diagnostics For USD 540 Million
December 12, 2018 05:26 PM AEDT| By Team Kalkine MediaSonic Healthcare Limited (ASX: SHL) has entered into a binding agreement to acquire Aurora Diagnostics, for USD$540million. The acquisition plan is in line with company?s objective of undertaking strategic and financially disciplined acquisitions in...
CardieX’s Pact With Blumio For Wearable Sensor Development Drives The Stock Higher
December 12, 2018 03:16 PM AEDT| By Team Kalkine MediaCardieX Limited (ASX: CDX) develops and manufactures medical devices. The Company produces a device that measures central aortic pressures and certain key heart function parameters non-invasively. The company has, via a recent ASX release stated tha...
CannPal Reports Positive Results For Phase 1B Study Of Animal Pain Control Drug CPAT-01
December 12, 2018 02:25 PM AEDT| By Team Kalkine MediaAs per ASX announcement on 12th December 2018, CannPal Animal Therapeutics Limited (ASX:CP1), animal health care company, has reported significant results in completing the dosing and live phase observations for its clinical Phase 1B study for CPAT-0...
Mayne Pharma’s Shares Uplifted after getting FDA Approval for Tolsura
December 12, 2018 01:16 PM AEDT| By Team Kalkine MediaSpecialty pharmaceutical company,? Mayne Pharma Group Limited (ASX: MYX) made an announcement on 12 December 2018 stating that its New Drug Application (NDA) for Tolsura? (SUBA?-itraconazole) has been approved by US Food and Drug Administration (FDA)...
Bionomics Receives Over $6.5 Million Tax Refund To Its Kitty
December 12, 2018 11:36 AM AEDT| By Team Kalkine MediaBIONOMICS LIMITED (ASX: BNO): A biopharmaceutical?company that treats diseases like cancer, psychological disorders such as anxiety, depression and Alzheimer's disease, has a vision to improve the lives of people who suffer from anxiety, depression,...
ASX:IHL Is Expanding Its Oral Devices’ Base In China And Asia
December 11, 2018 11:08 PM AEDT| By Team Kalkine MediaImpression Healthcare Limited (ASX: IHL) is an Australia based home dental impression company providing cost-effective dental healthcare products to the consumers at their door-step. It has its laboratory in Victoria. With its custom-fitted oral devi...
The Recent Achievements Could Not Impress The Investors Of OCC - Share Price Tumbled
December 11, 2018 07:23 PM AEDT| By Team Kalkine MediaOrthocell Limited (ASX: OCC) which is a Regenerative medicine company made two on 11 December 2018. One regarding the successful share placement where the company was able to generate $1.8 million and the second was the approval to use CelGro in key...
Advertise your brand on Kalkine Media